| URL | Priority | Change frequency | Last modified (GMT) |
|---|---|---|---|
| http://catalysthcc.com/2017/04/24/former-fda-associate-commissioner-jill-hartzler-warner-joins-catalyst-team-expanding-the-firms-expertise-in-regenerative-medicine-rare-disease-drug-development-and-combination-product-regul-2/ | 20% | Monthly | 2017-11-25 20:28 |
| http://catalysthcc.com/2017/04/21/trumps-deregulatory-agenda-implications-for-biopharma-medtech-companies/ | 20% | Monthly | 2021-07-26 19:57 |
| http://catalysthcc.com/2017/04/20/trumps-deregulatory-agenda-what-it-could-mean-for-biopharma-medtech-companies-2/ | 20% | Monthly | 2021-07-27 13:25 |
| http://catalysthcc.com/2017/04/20/trumps-deregulatory-agenda-what-it-could-mean-for-biopharma-medtech-companies/ | 20% | Monthly | 2017-11-25 20:30 |